145 related articles for article (PubMed ID: 7950894)
1. Morphological intermediate biomarkers in cancer chemoprevention.
Risio M
Eur J Cancer Prev; 1994 Jul; 3(4):366-8. PubMed ID: 7950894
[No Abstract] [Full Text] [Related]
2. Intermediate Biomarkers of Precancer and their Application in Chemoprevention. Workshop. Keystone, Colorado, October 3-7, 1991.
J Cell Biochem Suppl; 1992; 16G():1-196. PubMed ID: 1361588
[No Abstract] [Full Text] [Related]
3. Biological monitoring of cancer chemoprevention.
Pillai R; Garewal HS; Wood S; Watson RR
J Surg Oncol; 1992 Nov; 51(3):195-202. PubMed ID: 1434646
[TBL] [Abstract][Full Text] [Related]
4. Current trends in chemoprevention research.
Lipkin M
Eur J Cancer Prev; 1994 Jul; 3(4):368-71. PubMed ID: 7950895
[No Abstract] [Full Text] [Related]
5. Biomarkers as intermediate end points in chemoprevention trials.
Lippman SM; Lee JS; Lotan R; Hittelman W; Wargovich MJ; Hong WK
J Natl Cancer Inst; 1990 Apr; 82(7):555-60. PubMed ID: 2179569
[No Abstract] [Full Text] [Related]
6. Nutrition and chemoprevention controversies. 4th International Conference on Prevention of Human Cancer: June 3-6, 1992, Tucson, Arizona.
Pastorino U
Ann Oncol; 1993 Feb; 4(2):117-20. PubMed ID: 8095398
[No Abstract] [Full Text] [Related]
7. Biomarkers in cancer chemoprevention. Workshop report.
IARC Sci Publ; 2001; 154():1-12. PubMed ID: 11220649
[No Abstract] [Full Text] [Related]
8. Cancer chemoprevention: progress and promise.
Kelloff GJ; Sigman CC; Greenwald P
Eur J Cancer; 1999 Dec; 35(14):2031-8. PubMed ID: 10711244
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of human cancer: biology and therapy.
Tanaka T
Crit Rev Oncol Hematol; 1997 Apr; 25(3):139-74. PubMed ID: 9177939
[No Abstract] [Full Text] [Related]
10. Chemoprevention of cancer.
Sporn MB
Lancet; 1993 Nov; 342(8881):1211-3. PubMed ID: 7901533
[No Abstract] [Full Text] [Related]
11. Complex regulation of telomerase activity: implications for cancer therapy.
Elenitoba-Johnson KS
Am J Pathol; 2001 Aug; 159(2):405-10. PubMed ID: 11485897
[No Abstract] [Full Text] [Related]
12. International Meeting on Cancer Chemoprevention: molecular basis, mechanisms and trials.
Bartsch H; Frank N; Gerhäuser C; Owen RW; Berger MR
Eur J Cancer Prev; 1997 Feb; 6(1):80-92. PubMed ID: 9161817
[No Abstract] [Full Text] [Related]
13. Recent advances in chemoprevention of cancer.
Hong WK; Sporn MB
Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183
[TBL] [Abstract][Full Text] [Related]
14. Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?
Gyawali B
J Natl Compr Canc Netw; 2017 Jul; 15(7):859-862. PubMed ID: 28687572
[No Abstract] [Full Text] [Related]
15. Getting the details right: gene signatures for cancer therapy.
Master SR
Clin Chem; 2010 Sep; 56(9):1378-80. PubMed ID: 20592045
[No Abstract] [Full Text] [Related]
16. Cancer chemoprevention: progress and perspectives.
Bonovas S
Curr Drug Targets; 2011 Dec; 12(13):1871-3. PubMed ID: 21158713
[No Abstract] [Full Text] [Related]
17. Quantitative science methods for biomarker validation in chemoprevention trials.
Freedman L
Cancer Biomark; 2007; 3(3):135-40. PubMed ID: 17611304
[TBL] [Abstract][Full Text] [Related]
18. Zeroing in on individual cancer risk.
Marx J
Science; 1991 Aug; 253(5020):612-6. PubMed ID: 1651561
[No Abstract] [Full Text] [Related]
19. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
Scholler N
IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
[No Abstract] [Full Text] [Related]
20. Cancer stem cells: implications for cancer treatment and prevention.
Kakarala M; Wicha MS
Cancer J; 2007; 13(5):271-5. PubMed ID: 17921723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
